140 related articles for article (PubMed ID: 17981711)
1. Acid ceramidase inhibition: a novel target for cancer therapy.
Liu X; Elojeimy S; Turner LS; Mahdy AE; Zeidan YH; Bielawska A; Bielawski J; Dong JY; El-Zawahry AM; Guo GW; Hannun YA; Holman DH; Rubinchik S; Szulc Z; Keane TE; Tavassoli M; Norris JS
Front Biosci; 2008 Jan; 13():2293-8. PubMed ID: 17981711
[TBL] [Abstract][Full Text] [Related]
2. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
Elojeimy S; Liu X; McKillop JC; El-Zawahry AM; Holman DH; Cheng JY; Meacham WD; Mahdy AE; Saad AF; Turner LS; Cheng J; A Day T; Dong JY; Bielawska A; Hannun YA; Norris JS
Mol Ther; 2007 Jul; 15(7):1259-63. PubMed ID: 17426710
[TBL] [Abstract][Full Text] [Related]
3. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
Vijayan Y; Lankadasari MB; Harikumar KB
Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
[TBL] [Abstract][Full Text] [Related]
4. Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.
Cho SM; Kwon HJ
Arch Pharm Res; 2019 Mar; 42(3):232-243. PubMed ID: 30661200
[TBL] [Abstract][Full Text] [Related]
5. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
6. Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells.
Holman DH; Turner LS; El-Zawahry A; Elojeimy S; Liu X; Bielawski J; Szulc ZM; Norris K; Zeidan YH; Hannun YA; Bielawska A; Norris JS
Cancer Chemother Pharmacol; 2008 Feb; 61(2):231-42. PubMed ID: 17429631
[TBL] [Abstract][Full Text] [Related]
7. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
8. New insights on the use of desipramine as an inhibitor for acid ceramidase.
Elojeimy S; Holman DH; Liu X; El-Zawahry A; Villani M; Cheng JC; Mahdy A; Zeidan Y; Bielwaska A; Hannun YA; Norris JS
FEBS Lett; 2006 Aug; 580(19):4751-6. PubMed ID: 16901483
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeting of acid ceramidase: implications to cancer therapy.
Zeidan YH; Jenkins RW; Korman JB; Liu X; Obeid LM; Norris JS; Hannun YA
Curr Drug Targets; 2008 Aug; 9(8):653-61. PubMed ID: 18691012
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Ceramidases.
Saied EM; Arenz C
Chem Phys Lipids; 2016 May; 197():60-8. PubMed ID: 26220616
[TBL] [Abstract][Full Text] [Related]
11. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
12. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.
Govindarajah N; Clifford R; Bowden D; Sutton PA; Parsons JL; Vimalachandran D
Crit Rev Oncol Hematol; 2019 Jun; 138():104-111. PubMed ID: 31092365
[TBL] [Abstract][Full Text] [Related]
14. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
15. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.
Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Banno Y; Shinoda J; Sakai N
Cell Death Differ; 2004 Aug; 11(8):853-61. PubMed ID: 15088070
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
17. The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.
Tan SF; Pearson JM; Feith DJ; Loughran TP
Expert Opin Ther Targets; 2017 Jun; 21(6):583-590. PubMed ID: 28434262
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Liu X; Elojeimy S; El-Zawahry AM; Holman DH; Bielawska A; Bielawski J; Rubinchik S; Guo GW; Dong JY; Keane T; Hannun YA; Tavassoli M; Norris JS
Mol Ther; 2006 Nov; 14(5):637-46. PubMed ID: 16887394
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.
Morales A; París R; Villanueva A; Llacuna L; García-Ruiz C; Fernández-Checa JC
Oncogene; 2007 Feb; 26(6):905-16. PubMed ID: 16862171
[TBL] [Abstract][Full Text] [Related]
20. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells.
Castillo SS; Teegarden D
J Nutr; 2001 Nov; 131(11):2826-30. PubMed ID: 11694603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
